Trial Examines Short-term Effects of Hippotherapy on Fascia Properties and Quality of Life in Children With CP. (HYPPOTER25)

University Medical Centre Ljubljana

Status

Not yet enrolling

Conditions

Fascia

Rehabilitation

Quality of Life

Hippotherapy

Motor Coordination or Function

Cerebral Palsy (CP)

Treatments

Other: Hippotherapy 1x/week

Other: Hippotherapy 2x/week

Study type

Interventional

Funder types

Other

Identifiers

NCT07134582

HYPPOTER25

Details and patient eligibility

About

The effects of hippotherapy on gross motor function, balance, and spasticity in children with cerebral palsy (CP) are well-documented, but its impact on the thoracolumbar fascia (TLF) remains unexplored area to date. This research protocol aims to investigate the short-term effects of hippotherapy on the viscoelastic and biomechanical properties of the TLF and quality of life (QoL) in children with spastic CP and their parents/caregivers. A 4-week randomized control trial will compare the effects of once-weekly and twice-weekly hippotherapy sessions to a control group without intervention. The study will assess the viscoelastic and biomechanical properties of the TLF using the MyotonPRO device in children with spastic CP aged 4-12 years. Myotonometer parameters, including oscillation frequency, stiffness, logarithmic decrement, stress relaxation, and creep, will be analyzed before, during, and after the intervention. Functional tests, such as the 10-meter walk test (comfortable and fast walking), cadence, one-leg stance test (eyes open and closed), and functional reach test (forward and lateral), will also be monitored. QoL will be assessed using the CP QOL-Child questionnaire. The primary outcomes will include changes in myotonometer parameters, their correlation with functional tests, and differences between intervention groups. Secondary outcomes will explore whether hippotherapy impacts QoL and the relationship between QoL domains and TLF properties. Results will evaluate whether twice-weekly therapy yields statistically significant differences in the specified parameters compared once-weekly sessions and contribute to understanding hippotherapy's mechanisms, supporting more individualized therapies to improve QoL for children with CP and their families.

Enrollment

27 estimated patients

Sex

All

Ages

4 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

classified as level II or III according to the GMFCS, and who, according to the assessment of a specialist physician, are indicated for hippotherapy aged between 4 and 12 years
who are undergoing neurophysiotherapeutic treatment
who have not undergone orthopedic surgery in the last six months and do not have uncontrolled epilepsy
are willing to be randomly assigned to any group (or whose parents/caregiver's consent)
understand instructions in Slovene and are willing to participate in the study for four weeks (or whose parents/ caregiver's consent)
without skin diseases, scars, or wounds on the examined part of the back

Exclusion criteria

who have previously participated in a hippotherapy program
with a known and diagnosed psychiatric disorder for which hippotherapy is contraindicated
with limitations due to hearing or visual impairment
with painful adductor contractures, painful subluxation, or hip dislocation are not willing to be randomly assigned to any group (or whose parents/caregiver's consent)
who are afraid of horses or have an allergy to horsehair
with skin diseases, scars, or wounds on the examined part of the back